CLINICAL_TRIALS
trial_result
· 2024-03-26
Clinical Trial Update: A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD) [Phase 3]
Summary
Phase 3 trial assessing REL-1017 as monotherapy for major depressive disorder has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Relmada Therapeutics, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2024-03-26